Search Results - "Indira Chandran, Vineesh"

Refine Results
  1. 1
  2. 2
  3. 3

    Extracellular vesicles in glioblastoma: a challenge and an opportunity by Indira Chandran, Vineesh, Gopala, Srinivas, Venkat, Easwer Hariharan, Kjolby, Mads, Nejsum, Peter

    Published in NPJ precision oncology (17-05-2024)
    “…Glioblastoma is a highly heterogeneous tumor whose pathophysiological complexities dictate both the diagnosis of disease severity as well as response to…”
    Get full text
    Journal Article
  4. 4

    Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer by Godina, Christopher, Indira Chandran, Vineesh, Barbachowska, Magdalena, Tryggvadottir, Helga, Nodin, Björn, Visse, Edward, Borgquist, Signe, Jirström, Karin, Isaksson, Karolin, Bosch, Ana, Belting, Mattias, Jernström, Helena

    Published in Translational oncology (01-08-2022)
    “…•Breast tumor CAV1 levels were assessed in relation to phenotype and prognosis.•CAV1’s prognostic impact depended on anthropometric and tumor factors.•Stromal…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity by Christianson, Helena C, Menard, Julien A, Indira Chandran, Vineesh, Bourseau-Guilmain, Erika, Shevela, Dmitry, Lidfeldt, Jon, Månsson, Ann-Sofie, Pastorekova, Silvia, Messinger, Johannes, Belting, Mattias

    Published in Oncotarget (15-09-2017)
    “…Aggressive cancers are characterized by hypoxia, which is a key driver of tumor development and treatment resistance. Proteins specifically expressed in the…”
    Get full text
    Journal Article
  7. 7

    The prevalence and risk factors for cognitive impairment in obesity and NAFLD by Wernberg, Charlotte W, Grønkjær, Lea L, Gade Jacobsen, Birgitte, Chandran, Vineesh I, Krag, Aleksander, Graversen, Jonas H, Weissenborn, Karin, Vilstrup, Hendrik, Lauridsen, Mette M

    Published in Hepatology communications (01-07-2023)
    “…Severe obesity may be accompanied by cognitive dysfunction and NAFLD, but the associations remain unclear. We describe the prevalence and features of cognitive…”
    Get full text
    Journal Article
  8. 8
  9. 9

    HER2 and uPAR cooperativity contribute to metastatic phenotype of HER2-positive breast cancer by Indira Chandran, Vineesh, Eppenberger-Castori, Serenella, Venkatesh, Thejaswini, Vine, Kara Lea, Ranson, Marie

    Published in Oncoscience (2015)
    “…Human epidermal growth factor receptor type 2 (HER2)-positive breast carcinoma is highly aggressive and mostly metastatic in nature though curable/manageable…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Improved Pharmacokinetic and Biodistribution Properties of the Selective Urokinase Inhibitor PAI-2 (SerpinB2) by Site-Specific PEGylation: Implications for Drug Delivery by Vine, Kara Lea, Lobov, Sergei, Chandran, Vineesh Indira, Harris, Nathanial Lachlan Ewart, Ranson, Marie

    Published in Pharmaceutical research (01-03-2015)
    “…Purpose Overexpression of the serine protease urokinase (uPA) is recognised as an important biomarker of metastatic disease and a druggable anticancer target…”
    Get full text
    Journal Article
  14. 14

    Anti-cancer activity of an acid-labile N -alkylisatin conjugate targeting the transferrin receptor by Indira Chandran, Vineesh, Matesic, Lidia, Locke, Julie M, Skropeta, Danielle, Ranson, Marie, Vine, Kara L

    Published in Cancer letters (28-03-2012)
    “…Abstract We have previously reported a series of pH-sensitive imine-linked N -alkylisatin prodrugs that are stable at pH 7.4, but readily cleaved at pH 4.5…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20